Table 8 EU Guidelines, quality indicators (with accepted and desired levels)
From: Introduction of organised mammography screening in tyrol: results of a one-year pilot phase
Tyrol 50-69 | EU-accepted | EU-desired | |
|---|---|---|---|
Attendance proportion | 54.2 | >70 | >75 |
Recall rate1) | 3.1 (327/10521) | <7%/ <5% | <5%/ <3% |
Interval cancer rate/Background incidence rate (BIR) 0-11 months | 9% (two interval cancers in age 50-69) | 30% | <30% |
Breast cancer detection rate | 2.3 * BIR | 3*BIR | >3*BIR |
Stage II+/Total cancers screen-detected | 38.0% (19/50) | NA | <30% |
Invasive cancers ≤ 10 mm/Total invasive cancers | 34.0% (16/47) | NA | >= 25% |
Proportion of invasive cancers that are < 15 mm in size | 51.1% (24/47) | 50% | >50% |
Invasive cancer/Total cancers screen-detected | 94% (47/50) | 90% | 80%-90% |
Node-negative cancer/Total invasive cancers screen-detected | 66.0% (31/47) | NA | >70% |
Benign to malignant open surgical biopsy ratio | 0:1 (0:4) | <=1:2 | <=1:4 |
Benign to malignant core biopsy ratio | 1:0.9 (60:64) |